Kurt Orlofski

Mr. Kurt Orlofski

President and COO, G & W LABORATORIES, INC.


          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Member of the Healthcare Council

Request a consultation with Kurt Orlofski

Council Member Biography

Kurt Orlofski, CPA, CMA, is President and COO at G & W Laboratories. Mr. Orlofski was previously, President of Wockhardt USA (Apr 2007 - Aug 2009). Wockhardt is a global leader in pharmaceuticals and biotechnology. Previously, Mr. Orlofski was President and Chief Executive Officer of Pliva, the US subsidiary of the global specialty pharmaceutical company Pliva. He was responsible for all Pliva US businesses including USD300m of generics business. Previously, Mr. Orlofski was Senior Vice President of Global Business Development at Alpharma Human Pharmaceuticals. His areas of expertise include pharmaceutical general management, operations and quality management, sales and marketing in generics, new business unit start-ups, product acquisition, brand and generic in and out licensing of products and technology, business unit and asset sales and acquisitions including integration, contract manufacturing deals in and out, and negotiation and execution of supplier and customer supply agreements. (This is me - Update Profile)


Employment History

2009 - Unspecified
President and COO, G & W LABORATORIES, INC.
2007 - 2009
President , Wockhardt USA, Inc.
2004 - 2006
President and Chief Executive Officer, PLIVA INC.
2001 - 2004
Sr. Vice President of Global Business Development, ZOETIS PRODUCTS LLC

GLG Study Groups with Kurt Orlofski(?)

Study Group Name No. Members
Generic Drug Economic Experts 937

GLG Live Meetings with Kurt Orlofski(?)

Kurt Orlofski has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare